Cx-603

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCx-603
Drug Alias Nameallogeneic adipose-derived mesenchymal stem cells (Cellerix/TiGenix)allogeneic adipose-derived mesenchymal stem cells (TiGenix)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapy
Mechanisms of ActionStem cells modulators
TargetsUpdating
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumSpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCellerix Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTigenix NvCellerix Sa
Active IndicationsN/A
Inactive IndicationsOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A